id: covid_19_pandemic_to_oud_treatment_access_pregnant_patients
name: COVID-19 Pandemic â†’ OUD Treatment Access for Pregnant Patients
from_node:
  node_id: covid_19_pandemic
  node_name: COVID-19 Pandemic
to_node:
  node_id: oud_treatment_access_pregnant_patients
  node_name: OUD Treatment Access for Pregnant Patients
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: COVID-19 pandemic creates operational disruptions and safety concerns in
  healthcare facilities'
- 'Step 2: Buprenorphine clinics reduce capacity or restrict patient populations,
  particularly vulnerable groups'
- 'Step 3: Clinics that previously accepted pregnant patients for OUD treatment discontinue
  this service (33% reduction)'
- 'Step 4: Pregnant patients with OUD lose access to medication-assisted treatment,
  increasing risk of untreated opioid use disorder'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Ashley C. Lensch et al. 2021. "Pregnant Patients Using Opioids:
    Treatment Access Barriers in the Age of COVID-19." *Journal of addiction medicine*.
    https://doi.org/10.1097/ADM.0000000000000826'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.701903'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: pre_pandemic_treatment_barriers
  direction: strengthens
  strength: strong
  description: 48% of clinics already refused pregnant patients before pandemic, compounding
    pandemic-related reductions in access
